日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Temporal Machine Learning Analysis of Prior Mammograms for Breast Cancer Risk Prediction

基于时间序列机器学习的既往乳房X光片分析在乳腺癌风险预测中的应用

Li, Hui; Robinson, Kayla; Lan, Li; Baughan, Natalie; Chan, Chun-Wai; Embury, Matthew; Whitman, Gary J; El-Zein, Randa; Bedrosian, Isabelle; Giger, Maryellen L

Intralesional SD-101 in Combination with Pembrolizumab in Anti-PD-1 Treatment-Naïve Head and Neck Squamous Cell Carcinoma: Results from a Multicenter, Phase II Trial

在未接受过抗PD-1治疗的头颈部鳞状细胞癌患者中,病灶内注射SD-101联合帕博利珠单抗的疗效:一项多中心II期试验的结果

Cohen, Ezra E W; Nabell, Lisle; Wong, Deborah J; Day, Terry; Daniels, Gregory A; Milhem, Mohammed; Deva, Sanjeev; Jameson, Michael; Guntinas-Lichius, Orlando; Almubarak, Mohammed; Strother, Matthew; Whitman, Eric; Chisamore, Michael; Obiozor, Cynthia; Bagulho, Teresa; Gomez-Romo, Jose; Guiducci, Cristiana; Janssen, Robert; Gamelin, Erick; Algazi, Alain P

Microenvironment-Mediated Mechanisms of Resistance to HER2 Inhibitors Differ between HER2+ Breast Cancer Subtypes

HER2+ 乳腺癌亚型对 HER2 抑制剂的微环境介导耐药机制不同

Spencer S Watson, Mark Dane, Koei Chin, Zuzana Tatarova, Moqing Liu, Tiera Liby, Wallace Thompson, Rebecca Smith, Michel Nederlof, Elmar Bucher, David Kilburn, Matthew Whitman, Damir Sudar, Gordon B Mills, Laura M Heiser, Oliver Jonas, Joe W Gray, James E Korkola

Direct evidence for cancer-cell-autonomous extracellular protein catabolism in pancreatic tumors

胰腺肿瘤中癌细胞自主细胞外蛋白质分解代谢的直接证据

Shawn M Davidson, Oliver Jonas, Mark A Keibler, Han Wei Hou, Alba Luengo, Jared R Mayers, Jeffrey Wyckoff, Amanda M Del Rosario, Matthew Whitman, Christopher R Chin, Kendall J Condon, Alex Lammers, Katherine A Kellersberger, Brian K Stall, Gregory Stephanopoulos, Dafna Bar-Sagi, Jongyoon Han, Joshua

Synergistic interactions with PI3K inhibition that induce apoptosis

与 PI3K 抑制的协同作用可诱导细胞凋亡

Yaara Zwang, Oliver Jonas, Casandra Chen, Mikael L Rinne, John G Doench, Federica Piccioni, Li Tan, Hai-Tsang Huang, Jinhua Wang, Young Jin Ham, Joyce O'Connell, Patrick Bhola, Mihir Doshi, Matthew Whitman, Michael Cima, Anthony Letai, David E Root, Robert S Langer, Nathanael Gray, William C Hahn

Parallel In Vivo Assessment of Drug Phenotypes at Various Time Points during Systemic BRAF Inhibition Reveals Tumor Adaptation and Altered Treatment Vulnerabilities

在系统性 BRAF 抑制期间的不同时间点对药物表型进行平行体内评估,揭示肿瘤适应性和改变的治疗弱点

Oliver Jonas, Madeleine J Oudin, Tatsiana Kosciuk, Matthew Whitman, Frank B Gertler, Michael J Cima, Keith T Flaherty, Robert Langer